These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37963437)

  • 1. Ivabradine could not decrease mitral regurgitation triggered atrial fibrosis and fibrillation compared with carvedilol.
    Lee WC; Lin YW; Shih JY; Chen ZC; Wu NC; Chang WT
    ESC Heart Fail; 2024 Feb; 11(1):251-260. PubMed ID: 37963437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapagliflozin Improves Cardiac Hemodynamics and Mitigates Arrhythmogenesis in Mitral Regurgitation-Induced Myocardial Dysfunction.
    Lin YW; Chen CY; Shih JY; Cheng BC; Chang CP; Lin MT; Ho CH; Chen ZC; Fisch S; Chang WT
    J Am Heart Assoc; 2021 Apr; 10(7):e019274. PubMed ID: 33749310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
    Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
    Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate reduction improves biventricular function and interactions in experimental pulmonary hypertension.
    Gomez O; Okumura K; Honjo O; Sun M; Ishii R; Bijnens B; Friedberg MK
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H542-H551. PubMed ID: 29146614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivabradine for the Treatment of Acute Mitral-Regurgitation-Related Decompensated Heart Failure.
    Lee WC; Fang HY
    Cardiology; 2019; 144(3-4):97-100. PubMed ID: 31533098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralocorticoid Receptor Antagonists Mitigate Mitral Regurgitation-Induced Myocardial Dysfunction.
    Chang WT; Lin YW; Chen CY; Chen ZC; Shih JY; Wu CC; Luo CY; Liu PY
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure.
    Lowes BD; Gill EA; Abraham WT; Larrain JR; Robertson AD; Bristow MR; Gilbert EM
    Am J Cardiol; 1999 Apr; 83(8):1201-5. PubMed ID: 10215284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation.
    Lin YS; Jan JY; Chang JJ; Lin MS; Yang TY; Wang PC; Chen MC
    ESC Heart Fail; 2022 Aug; 9(4):2548-2557. PubMed ID: 35560828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial).
    Volterrani M; Cice G; Caminiti G; Vitale C; D'Isa S; Perrone Filardi P; Acquistapace F; Marazzi G; Fini M; Rosano GM
    Int J Cardiol; 2011 Sep; 151(2):218-24. PubMed ID: 21764469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitral valve repair for atrial functional mitral regurgitation in patients with chronic atrial fibrillation.
    Takahashi Y; Abe Y; Sasaki Y; Bito Y; Morisaki A; Nishimura S; Shibata T
    Interact Cardiovasc Thorac Surg; 2015 Aug; 21(2):163-8. PubMed ID: 25980774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta blockers improve outcome in patients with heart failure and atrial fibrillation: U.S. carvedilol study.
    Ramaswamy K
    Card Electrophysiol Rev; 2003 Sep; 7(3):229-32. PubMed ID: 14739719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.
    Yue-Chun L; Teng Z; Na-Dan Z; Li-Sha G; Qin L; Xue-Qiang G; Jia-Feng L
    PLoS One; 2012; 7(6):e39394. PubMed ID: 22761780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of ivabradine in cardiogenic shock.
    Chiu MH; Howlett JG; Sharma NC
    ESC Heart Fail; 2019 Oct; 6(5):1088-1091. PubMed ID: 31332966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?
    Khand AU; Rankin AC; Martin W; Taylor J; Gemmell I; Cleland JG
    J Am Coll Cardiol; 2003 Dec; 42(11):1944-51. PubMed ID: 14662257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does atrial fibrillation in elderly patients with chronic heart failure limit the efficacy of carvedilol? Suggestions from an observational study.
    Opasich C; De Feo S; Cioffi G; Pulignano G; Del Sindaco D; Tarantini L; Gualco A; Patrignani A
    Ital Heart J; 2005 Apr; 6(4):323-7. PubMed ID: 15902931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Combination of Valsartan and Spironolactone Mitigated Mitral Regurgitation-Induced Cardiac Dysfunction in a Novel Rat Model.
    Chang WT; Lin YW; Chen CY; Hong CS; Chen ZC; Lin YC; Shih JY
    J Cardiovasc Pharmacol; 2024 Oct; 84(4):410-417. PubMed ID: 39115805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Neprilysin Inhibition for Ischemic Mitral Regurgitation after Myocardial Injury.
    Lee S; Hwang HS; Song N; Kang GH; Choi KH; Ji E; Song JM; Kang DH
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of Atrial Fibrillation on the Mechanisms of Mitral Regurgitation and Response to MitraClip in the COAPT Trial.
    Gertz ZM; Herrmann HC; Lim DS; Kar S; Kapadia SR; Reed GW; Puri R; Krishnaswamy A; Gersh BJ; Weissman NJ; Asch FM; Grayburn PA; Kosmidou I; Redfors B; Zhang Z; Abraham WT; Lindenfeld J; Stone GW; Mack MJ
    Circ Cardiovasc Interv; 2021 Apr; 14(4):e010300. PubMed ID: 33719505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.
    Bocchi EA; Böhm M; Borer JS; Ford I; Komajda M; Swedberg K; Tavazzi L;
    Cardiology; 2015; 131(4):218-24. PubMed ID: 25968495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study.
    Bagriy AE; Schukina EV; Samoilova OV; Pricolota OA; Malovichko SI; Pricolota AV; Bagriy EA
    Adv Ther; 2015 Feb; 32(2):108-19. PubMed ID: 25700807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.